GSK1120212+GSK2141795 for Cervical Cancer

NCT01958112 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Drug supply

Conditions

Cervical Cancer

Interventions

DRUG: GSK1120212 (trametinib)
DRUG: GSK2141795

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]